Navigation Links
Press statement on new CDC MRSA study from SHEA president
Date:2/17/2009

A new study from the Centers for Disease Control and Prevention (CDC) shows a decrease in catheter-associated bloodstream infections caused by both methicillin-resistant and methicillin-sensitive S. aureus. The 10-year national study, 'Methicillin-Resistant Staphylococcus aureus Central Line-Associated Bloodstream Infections in US Intensive Care Units, 1997,' reported data from both the National Nosocomial Infection Surveillance (NNIS) and its successor, the National Healthcare Safety Network (NHSN). The study demonstrates a steady decline in intensive care unit catheter-associated MRSA bloodstream infections since 2001.

Below Are Quotes from Mark Rupp, MD, President of SHEA

"Despite the fact that MRSA prevalence continues to rise, efforts to prevent catheter infections are paying dividends and the number of infections due to all types of Staphylococcus aureus, including MRSA, have been falling sharply since 2001. Therefore, simply examining the percentage of staphylococcal isolates that are MRSA can be a misleading indicator of the burden of disease caused by this organism."

"The rate of these infections is decreasing and hospitals are becoming safer for patients because hospitals are instituting and adhering to general practices that result in fewer infections, including measures to ensure proper catheter insertion and removal, hand hygiene, environmental cleanliness, and antimicrobial stewardship.

"Because MRSA only causes about 8% of healthcare-associated infections, it is critical that we not concentrate all of our preventive efforts on a single bacterium. Undue emphasis on a single organism like MRSA can dilute broader-based measures that can have a dramatic effect on infections caused by many different organisms.

"This study illustrates that it is more important for hospitals to focus on the infections and diseases that the germs cause rather than the germs themselves. Decreasing the infections will decrease the burden of disease caused by all resistant organisms and not just MRSA."


'/>"/>

Contact: Sharon Reis
sreis@gymr.com
202-745-5103
GYMR
Source:Eurekalert

Related biology news :

1. Molecule that suppresses immune response under study in type 1 diabetes
2. UNC study: Tinkering with the circadian clock can suppress cancer growth
3. Pregnancy hormone predicts postpartum depression
4. American Chemical Societys Weekly PressPac -- Jan. 28, 2009
5. DNA component can stimulate and suppress the immune response
6. Cutting salt isnt the only way to reduce blood pressure
7. American Chemical Societys weekly PressPac -- Jan. 14, 2009
8. American Chemical Societys Weekly PressPac -- Jan. 7, 2009
9. Facial expressions of emotion are innate, not learned, says new study
10. Krumlauf Lab demonstrates modulation of gene expression by protein coding regions
11. American Chemical Societys Weekly PressPac -- Dec. 17, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... 2021 from $8.3 billion in 2016 at a compound ... 2021. Report Includes - An overview of the ... trends, with data from 2015 and 2016, and projections ... Segmentation of the market on the basis of product ...
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:2/6/2017)... , Feb. 6, 2017 According ... security are driving border authorities to continue to ... reports there are 2143 Automated Border Control (ABC) ... currently deployed at more than 163 ports of ... 2013 to 2016 achieving a combined CAGR of ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... ... February 17, 2017 , ... Academy of Model Aeronautics ... leading maker of unmanned aircraft systems (UAS), are launching a joint program to ... effectively, and support educational outreach efforts. , AMA and DJI will collaborate on ...
(Date:2/16/2017)... 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company ... better treatment for triple negative breast cancer (TNBC), announced today ... program. The YEi Start in ... help entrepreneurs grow their business in France ... companies selected to complete an intensive one week immersion in ...
(Date:2/16/2017)... Research and Markets has announced ... report to their offering. ... The study ... delivery plasmids, chassis organisms, synthetic cells, production systems), enabling ... bioinformatics and specialty media) and enabled technologies (biofuels, chemicals, ...
(Date:2/16/2017)... Feb. 16, 2017 UCHealth ( Aurora, ... LungDirect for pulmonary nodule patient management. In addition to ... a spot on the lung, UCHealth looks to improve ... data entry. Stephanie Brown, RN , ... nodule patients with an Excel spreadsheet, which was extremely ...
Breaking Biology Technology: